Lucid Diagnostics Inc. / Fundamentals
Income statement
- Net revenue
€3.76M - Cost of goods sold
€6.17M - Gross profit
-€2.42M - SG&A expenses
€33.62M - R&D expenses
€5.00M - EBITDA
-€46.83M - D&A
€758.16K - EBIT
-€41.30M - Interest expenses
-€7.74M - EBT
-€47.61M - Tax expenses
€10.82B - Net income
-€47.61M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€6.44B - Changes in working capital
€702.16K - Operating cash flow
-€19.84B - Capex
€524.68K - Other investing cash flow
-€435.08M - Net investing cash flow
-€435.27M - Total cash dividends paid
€0.00 - Issuance of common stock
€38.51B - Debt repayment
€15.51M - Other financing cash flow
€14.47B - Net financing cash flow
€27.50B - Foreign exchange effects
€0.00 - Net change in cash
€7.55B - Cash at end of period
€26.81B - Free cash flow
-€19.84B
Balance sheet
- Cash and cash equivalents
€26.81M - Cash and short-term investments
€26.81M - Total receivables
€321.36K - Inventory
€845.18K - Other current assets
€1.17M - Total current assets
€29.15M - Property, plant & equipment
€2.74M - Goodwill
€0.00 - Intangible assets
€453.17K - Long-term investments
€0.00 - Other non-current assets
€969.24K - Total non-current assets
€4.17M - Total assets
€33.32M - Accounts payable
€717.67K - Short-term debt
€22.55M - Other current liabilities
€2.09M - Total current liabilities
€25.35M - Long-term debt
€22.99B - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€1.19M - Total liabilities
€26.54M - Common stock
€87.88K - Retained earnings
-€213.38M - Other equity
€0.00 - Total equity
€6.77M - Total liabilities and shareholders' equity
€33.32M
Company information
- Market capitalization
€107.97M - Employees
72 - Enterprise Value
€10.17B
Company ratios
- Gross margin
-
-64.3% Much worse than peer group: 54.0% - EBITDA margin
-
-1,246.7% Much worse than peer group: -605.8% - EBIT margin
-
-1,099.5% Much worse than peer group: -594.7% - EBT margin
-
-1,267.4% Much worse than peer group: -797.1% - Net margin
-
-1,267.4% Much worse than peer group: 2,009.2% - ROE
-
-702.9% Much worse than peer group: -609.8% - ROA
-
-142.9% Much worse than peer group: -96.5% - Asset turnover
-
11.3% Much worse than peer group: 56.7% - FCF margin
-
-528,317.8% Much worse than peer group: -595.9% - FCF yield
-18,380.0% - Efficiency ratio
1,346.7% - Net sales per employee
-
€52.17K - Net income per employee
-
-€661.23K